IRCT20201221049787N1 IRCT 2021-01-16 Shahre-kord University of Medical Sciences Magnesium Oxide and Vitamin C in Migraine Comparison of the Effectiveness of Magnesium Oxide and Vitamin C Supplementation in Prevention of Migraine Headaches 2021-01-20 anticipated 82 Complete https://irct.ir/trial/53185 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization by random number table method: After filling the informed consent of the study participants, patients will be divided into two groups by random number table method and will receive and consume one of the two drugs studied in the plan, Blinding description: Double blind blindness: The clinical researcher and the patients participating in the project are not aware of the type of drug used and only the clinical caregiver, knowing the type of drug, distributes it in similar envelopes. It should be noted that the drugs are similar in dose, color and shape. Also, the envelopes are nameless and recognizable only to the clinical caregiver. 2 Condition 1: Common Migraines. Condition 2: Classic Migraine. Intervention 1: Intervention group: Magnesium oxide tablets 250 mg once daily orally for 8 weeks. Intervention 2: Intervention group: Vitamin C 250 mg tablets once daily orally for 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information